The Department of HUGEN is pleased to announce the promotion of QUASAR PADIATH to associate professor with tenure. His primary research interest is molecular mechanisms of neurological disorders, especially myelin formation and maintenance, using data on humans and mouse and fruit fly models.
MEDICAL X-PRESS - "At least 18 percent of individuals with pancreatic cancer and a personal history of other HBOC- or LS-related cancers carry mutations in a pancreatic cancer susceptibility gene based on our data, suggesting that criteria for genetic testing in individuals with pancreatic cancer should include consideration of previous cancer history," concludes HUGEN's BETH DUDLEY and colleagues.
HEALTH NEWS DIGEST - The current movement in breast cancer research is matching DNA with targeted therapies and HUGEN's ADRIAN LEE is at the forefront. "We know now that no two cancers are alike...the concept is, with our ability to more comprehensively understand the genetic basis of the disease, we can more precisely understand the disease, and then treat the disease and/or predict risk."
STREET INSIDER - Human genetic’s JERRY VOCKLEY, principal investigator on the program, noted, “I am very excited about our Phase 2 and other clinical results showing the near elimination of hypoglycemia and reduction in cardiomyopathy, addressing two of the major life-threatening symptoms in these disorders. A reduction in the frequency of rhabdomyolysis episodes will also greatly improve the lives of our patients. I look forward to continue work...
UPMC/PITT HEALTH SCIENCES NEWSROOM - Public health and dental medicine geneticists from the University of Pittsburgh found that at least 49 genes underlie earlobe attachment. What does this research mean and why is it important?
POST-GAZETTE - “We think we have the cure for the looming superbug epidemic,” DIETRICH STEPHAN recalled the 41-year-old entrepreneur saying. “I said, ‘Oh, really. Send us all your stuff.’” The introduction paid off. Steckbeck’s company, Oakland-based Peptilogics Inc., recently closed on a $5.5 million Series A financing round led by Facebook Inc.’s first major investor Peter Thiel. Stephan, a serial entrepreneur and chair of Pitt Public Health’s ...
CURE - “New technology is allowing us to find cancers that may have a (previously unknown) infectious origin,” says PATRICK MOORE, professor of infectious diseases, microbiology, molecular genetics, and biochemistry. He is credited with co-discovering viral links to two types of skin cancer: Kaposi sarcoma and Merkel cell carcinoma.
POST-GAZETTE - Serial entrepreneur and human genetics chair DIETRICH STEPHAN will serve as CEO of Pitt's new business accelerator, backing a push to leverage Western PA’s strengths in the life sciences with private investors. The 10-year goal is to tackle prevalent and intractable global diseases. The initial focus will be on cancer, Alzheimer’s, multidrug-resistant bacterial infections, obesity, diabetes, and rare genetic diseases.
POPULAR SCIENCE - Geneticists often don’t like to perform population studies at such scale because they are too large to zoom in on any specific details. But that means that we might not be getting the full picture. Research by JOHN SHAFFER, ELEANOR FEINGOLD, and SETH WEINBERG tells us that there’s power in numbers. Just as seemingly simple traits reveal their true complexity, diseases that currently puzzle us will soon become easier to understan...
MIMS TODAY - “Treatability may not be the only consideration people have regarding such information,” says LISA PARKER, a HUGEN researcher who directs Pitt’s Centre for Bioethics and Health Law.
Alumni, faculty, students, and friends of the Department of Human Genetics got together in Orlando, Florida, during the November 2017 annual meeting of the American Society of Human Genetics (ASHG). It was a great reception, offering opportunities to catch up on careers, research, and school news. View more photos at bit.ly/2ioVwCd .
JOHN SHAFFER, assistant professor in the Department of Human Genetics at Pitt Public Health, and Seth Weinberg, an associate professor in the Department of Oral Biology at the School of Dental Medicine, received a grant award of $1.7 million from the National Institute of Dental and Craniofacial Research (NIDCR) for their project, “The Genetic Architecture of Human Facial Morphology.”
Researcher SUZANNE GOLLIN, Department of Human Genetics, has been reappointed as a member of the Pennsylvania Cancer Control, Prevention, and Research Advisory Board. This was confirmed by the Senate on September 20, 2017. She is pictured here with an image of tumor cell biomarkers.
NATURE COMMUNICATIONS - ANNE NEWMAN, EPI chair, is co-author of a recent article on the largest, most comprehensive genetic study of lean mass to date. By understanding the genetic contributions to lean mass—an indicator of muscle mass—future treatments may be developed to prevent the loss of lean mass with aging. With age, some people develop a condition called “sarcopenia” where they lose critical amounts of muscle mass, to the point that they ...